Last reviewed · How we verify

Accidental poisoning by lead and its compounds and fumes — Treatment Landscape & Competitive Intelligence

Accidental poisoning by lead and its compounds and fumes (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Accidental poisoning by lead and its compounds and fumes, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Calcium Disodium Versenate EDETIC ACID Medicis Anti-coagulant Amyloid beta A4 protein 1953-01-01
Bal DIMERCAPROL Provepharm Sas alpha-Adrenergic Agonist [EPC] 1946-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. · 1 drug in Accidental poisoning by lead and its compounds and fumes
  2. Medicis · 1 drug in Accidental poisoning by lead and its compounds and fumes
  3. Provepharm Sas · 1 drug in Accidental poisoning by lead and its compounds and fumes

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Accidental poisoning by lead and its compounds and fumes:

Cite this brief

Drug Landscape (2026). Accidental poisoning by lead and its compounds and fumes — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/accidental-poisoning-by-lead-and-its-compounds-and-fumes. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing